Government Bill (Senate)- Bill S-5 - Connected Care-An Act respecting the interoperability of health information technology and to prohibit data blocking by health information technology vendors Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector Public Bill (Senate) S-243- National Framework for Women's Health Federal life sciences strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, health system planning and resilience. Canadian-United States-Mexico Agreement (CUSMA) with respect to provisions relating to medical devices and technologies Federal life sciences strategy with respect to global value chain and supply chain management and investment towards medical technology manufacturing and export. Federal budget with respect to medical technology and device innovation and adoption, support and delivery of new models of care, equitable healthcare access, innovation, womens health, and investments in long-term care and home care Discuss policies around healthcare system resiliency, health system planning, infection prevention, medication errors, women's health, and health equity including access Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes.